Infinergy.

Infinergy is dicaffeine malate, roughly three quarters caffeine by weight bound to malic acid. Stacking it with anhydrous caffeine adds directly to one total caffeine dose rather than supplying a second mechanism, so the amounts must be summed.

The malate salt dissociates in the gut and releases free caffeine, which then blocks adenosine A1 and A2A receptors exactly as any other caffeine source does. Two caffeine sources in one formula are one pharmacological load.

Caffeine raises cortical arousal by blocking adenosine receptors, while theanine raises alpha wave activity and damps the glutamatergic edge of that arousal. The pairing keeps the alertness and softens the jittery feel, which is why it is the most widely used stack in the category.

Methylliberine is a methylurate purine that also antagonises adenosine receptors but with a different onset and clearance curve. Formulators pair it with a caffeine salt to broaden the timing of one shared mechanism, so total adenosine blockade should be counted together.

Melatonin signals the timing for sleep onset while caffeine blocks the adenosine receptors that carry accumulated sleep pressure. Taken close together the caffeine works against the signal the melatonin is sending, so they belong at opposite ends of the day.

Catechins inhibit catechol-O-methyltransferase, the enzyme that clears noradrenaline, while caffeine raises its release and blocks phosphodiesterase. Slowing the breakdown of what the other releases is a genuine two-step interaction on normal thermogenesis.

Caffeine raises catecholamine signalling but supplies no substrate for making more. Tyrosine is the amino acid precursor for dopamine and noradrenaline, so it refills what heightened output draws on.

Caffeine has a modest calciuric effect, increasing how much calcium leaves in urine per dose. At high daily caffeine intakes that loss is worth offsetting on the intake side rather than ignoring.

Taurine appears with caffeine salts in most energy formulas because it is an osmolyte and a modulator of inhibitory neurotransmission, so it sits on a different axis from adenosine antagonism. The pairing is a formulation convention with a mechanistic rationale rather than a co-tested combination for this specific salt. Nothing here says the pair produces a smoother subjective effect.

Alpha-GPC supplies choline for acetylcholine synthesis, while the caffeine released from dicaffeine malate blocks adenosine receptors. Two separate signalling routes, which is why pre-workout formulas stack them. Combination trials of the two are not what grounds this row; the biochemistry of each half is.

CDP-choline feeds both choline and cytidine into membrane phospholipid and acetylcholine pathways. Paired with a caffeine salt it is a formulation choice built on non-overlapping mechanisms. Evidence for the specific pair is not established.

Creatine loads the phosphocreatine pool that resynthesises ATP during short efforts; caffeine works on adenosine receptors in the central nervous system. The two do not share a pathway, which is the reason they coexist in the same scoop. Older reports of caffeine blunting creatine's ergogenic effect exist, so this pairing is not a settled additive one.

Beta-alanine raises muscle carnosine over weeks and buffers intracellular acidity; a caffeine salt acts within the hour on the central nervous system. The pairing reflects different time courses in one product rather than a shared mechanism.

Citrulline raises arginine availability for nitric oxide synthesis, which tends toward vasodilation, while caffeine tends to raise blood pressure acutely in people who are not habituated. The net vascular effect of the pair is not a simple sum and should be regarded as direction-dependent. Anyone tracking blood pressure has reason to know both are in the formula.

Caffeine is a mild diuretic and increases urinary loss of divalent cations, magnesium among them. Habitual high intake alongside a marginal magnesium intake is a plausible reason to attend to magnesium status. This is a handling effect on a mineral, not evidence that either changes the other's action.

Increased urine flow after a caffeine dose carries electrolytes with it, potassium included. The size of the loss in habitual users is small and tolerance to the diuretic effect develops. Relevant mainly where sweat losses are already high.

Caffeinated pre-workout products often carry sodium, potassium and magnesium because the caffeine component increases urine output during a session where sweat losses are also occurring. The pairing addresses fluid balance, not stimulant pharmacology.

Valerian acts on GABAergic sedation; the caffeine liberated from dicaffeine malate antagonises adenosine and opposes that. Taken in the same window the two work against each other, which is a timing question rather than a benefit. Worth flagging on any label that carries both.

Oral GABA crosses the blood-brain barrier poorly, so the pharmacological opposition to a stimulant is more theoretical than measured. Where a formula pairs them the intended framing is calm focus. The mechanism for oral GABA itself is not established.

Passionflower is used for its calming flavonoid content and pulls in the opposite direction from adenosine antagonism. Co-formulation is a taste and timing decision. No combination data grounds a net effect.

Ashwagandha is studied for effects on cortisol and the stress axis, while caffeine acutely raises cortisol and catecholamine output. The pair is often marketed as balancing, which the mechanisms make plausible and no combination trial establishes.

Rhodiola is studied for perceived exertion and mental fatigue through monoaminergic effects; caffeine works on adenosine receptors. Stacking them is a formulation habit built on two independent stories.